Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Home
»
Analysts
»
Kevin Strang
Kevin Strang
Stock Analyst at Goldman Sachs
(0.70)
# 4,080
Out of 4,592 analysts
3
Total ratings
33.3%
Success rate
-20.6%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
Stocks Rated by Kevin Strang
Stock
Action
Price Target
Current
Upside
Ratings
Updated
PRAX
Praxis Precision Medicines
Initiated Coverage:
Buy
$447
$307.83
+45.21%
2
Jul 17, 2026
STOK
Stoke Therapeutics
Initiated Coverage:
Buy
$44
$28.86
+52.46%
1
Jul 13, 2026
PRAX
Praxis Precision Medicines
Jul 17, 2026
Initiated Coverage:
Buy
Price Target:
$447
Current: $307.83
Upside:
+45.21%
2 Ratings
View All
STOK
Stoke Therapeutics
Jul 13, 2026
Initiated Coverage:
Buy
Price Target:
$44
Current: $28.86
Upside:
+52.46%
1 Ratings
View All